Bhupesh Singla Has Been Elected As a Fellow of the American Heart Association – UTHSC College of Pharmacy
UTHSC (The University of Tennessee Health Science Center) College of Pharmacy shared a post on LinkedIn:
“Congratulations to Dr. Bhupesh Singla, Assistant Professor in the College of Pharmacy’s Department of Pharmaceutical Sciences, who has been elected as a Fellow of the American Heart Association (FAHA) by the Council on Arteriosclerosis, Thrombosis, and Vascular Biology.
This prestigious honorary title is awarded to physicians, scientists, nurses, and healthcare professionals who have demonstrated a sustained record of excellence and made significant contributions to cardiovascular and stroke research, clinical practice, education, and leadership.
Dr. Singla’s research investigates the role of matricellular proteins in the development and progression of cardiometabolic diseases, including atherosclerosis and metabolic dysfunction-associated steatotic liver disease.
Election as an FAHA recognizes Dr. Singla’s scientific distinction and expertise in cardiovascular research.
His research work has been published in high-impact journals, and he has a strong and consistent record of securing funding for basic science research, including a predoctoral fellowship, two postdoctoral fellowships, an NIH K99/R00 award, an NIH R01 grant, and several institutional intramural grants.
In addition to his research achievements, Dr. Singla is committed to mentoring trainees and actively contributes to service at the institutional, national, and international levels.
‘I am deeply honored to be elected as a Fellow of the American Heart Association,’ said Dr. Singla. ‘This recognition reflects the collective efforts and dedication of my trainees, collaborators, and mentors.’
The AHA is a leading voluntary health organization devoted to fighting cardiovascular disease and stroke.
Fellowship in the AHA recognizes not only scientific accomplishments but also dedication to the organization’s mission to build healthier lives free of cardiovascular disease and stroke.”
Stay updated with Hemostasis Today.
-
Oct 8, 2026, 04:28Jeff Molter: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 04:23Barbara Adams Krolak: Women and Blood Clots Are We Missing the Warning Signs
-
Oct 8, 2026, 04:10Rutendo Muzambi: Hospital Admission Patterns and Care Disparities in Sickle Cell Disease
-
Oct 8, 2026, 03:50Olfat Berro: Redefining the Future of Haemophilia A
-
Oct 8, 2026, 03:35Tasnia Tarana: Heavy Menstrual Bleeding When the Cause Is Not in the Uterus
-
Oct 8, 2026, 03:28Kian Haseli: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 03:20Sthanu Subramanian: Leukopenia in Sepsis A Marker of Severe Disease
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target